Removing Race From Hyperbilirubinemia Guidelines Is Not Enough

Sharon Ostfeld-Johns; Elena Aragona; Louis Hart

doi:10.1001/jamapediatrics.2022.3865

Removing Race From Hyperbilirubinemia Guidelines Is Not Enough

JAMA Pediatr. 2022 Dec 1;176(12):1163-1164. doi: 10.1001/jamapediatrics.2022.3865.

Authors

Sharon Ostfeld-Johns^{1

2}, Elena Aragona¹, Louis Hart^{1

3}

Affiliations

¹ Section of Hospital Medicine, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
² Section of General Internal Medicine Program in Hospital Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
³ Office of Health Equity, Yale New Haven Health System, New Haven, Connecticut.

PMID: 36251301
DOI: 10.1001/jamapediatrics.2022.3865

No abstract available

Plain language summary

This Viewpoint discusses the complexities of race-conscious medicine and the importance of more explicit and attentive guidance in treatment recommendations.

MeSH terms

Humans
Hyperbilirubinemia, Neonatal* / therapy
Infant, Newborn